Skip to main content

STK-03: Anticoagulation Therapy for Atrial Fibrillation/Flutter

CBE ID
0436
1.4 Project
Neurology
Endorsed
Endorsement Status
Endorsed with Reserve Status
E&M Cycle
Full Year 2015
Is Under Review
No
1.3 Measure Description

This measure captures the proportion of ischemic stroke patients with atrial fibrillation/flutter who are prescribed anticoagulation therapy at hospital discharge.

This measure is a part of a set of eight nationally implemented measures that address stroke care (STK-1: Venous Thromboembolism (VTE) Prophylaxis, STK-2: Discharged on Antithrombotic Therapy, STK-4: Thrombolytic Therapy, STK-5: Antithrombotic Therapy By End of Hospital Day 2, STK-6 Discharged on Statin Medication, STK-8: Stroke Education, and STK-10: Assessed for Rehabilitation) that are used in The Joint Commission’s hospital accreditation and Disease-Specific Care certification programs.

    • 1.14 Numerator

      Ischemic stroke patients prescribed anticoagulation therapy at hospital discharge

    • 1.15 Denominator

      Ischemic stroke patients with documented atrial fibrillation/flutter.

    • Exclusions

      • Less than 18 years of age
      • Length of Stay > 120 days
      • Comfort measures only documented
      • Enrolled in clinical trials related to stroke
      • Admitted for elective carotid intervention
      • Discharged to another hospital
      • Left against medical advice
      • Expired
      • Discharged to home for hospice care
      • Discharged to a health care facility for hospice care
      • Documented reason for not prescribing anticoagulation therapy at discharge

    • Most Recent Endorsement Activity
      Endorsed with Reserve Status Neurology Project 2015-2016
      Initial Endorsement
      Last Updated
    • Steward
      The Joint Commission
      Steward Organization Email
      [email protected]
      Steward Organization Copyright

      No royalty or use fee is required for copying or reprinting this manual, but the following are required as a condition of usage: 1) disclosure that the Specifications Manual is periodically updated, and that the version being copied or reprinted may not be up-to-date when used unless the copier or printer has verified the version to be up-to-date and affirms that, and 2) users participating in Joint Commission accreditation, including ORYX® vendors, are required to update their software and associated documentation based on the published manual production timelines.